93 related articles for article (PubMed ID: 38555418)
21. A cross-study analysis of drug response prediction in cancer cell lines.
Xia F; Allen J; Balaprakash P; Brettin T; Garcia-Cardona C; Clyde A; Cohn J; Doroshow J; Duan X; Dubinkina V; Evrard Y; Fan YJ; Gans J; He S; Lu P; Maslov S; Partin A; Shukla M; Stahlberg E; Wozniak JM; Yoo H; Zaki G; Zhu Y; Stevens R
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34524425
[TBL] [Abstract][Full Text] [Related]
22. Metastatic heterogeneity of the consensus molecular subtypes of colorectal cancer.
Eide PW; Moosavi SH; Eilertsen IA; Brunsell TH; Langerud J; Berg KCG; Røsok BI; Bjørnbeth BA; Nesbakken A; Lothe RA; Sveen A
NPJ Genom Med; 2021 Jul; 6(1):59. PubMed ID: 34262039
[TBL] [Abstract][Full Text] [Related]
23. Down-Regulation of an Autophagy-Related Gene
Fu C; Yu Z; He Y; Ding J; Wei M
Onco Targets Ther; 2021; 14():3861-3872. PubMed ID: 34188492
[TBL] [Abstract][Full Text] [Related]
24. A Prognostic Nomogram of Colon Cancer With Liver Metastasis: A Study of the US SEER Database and a Chinese Cohort.
Liu C; Hu C; Huang J; Xiang K; Li Z; Qu J; Chen Y; Yang B; Qu X; Liu Y; Zhang G; Wen T
Front Oncol; 2021; 11():591009. PubMed ID: 33738248
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review.
Biller LH; Schrag D
JAMA; 2021 Feb; 325(7):669-685. PubMed ID: 33591350
[TBL] [Abstract][Full Text] [Related]
26. Whole genome sequencing of metastatic colorectal cancer reveals prior treatment effects and specific metastasis features.
Mendelaar PAJ; Smid M; van Riet J; Angus L; Labots M; Steeghs N; Hendriks MP; Cirkel GA; van Rooijen JM; Ten Tije AJ; Lolkema MP; Cuppen E; Sleijfer S; Martens JWM; Wilting SM
Nat Commun; 2021 Jan; 12(1):574. PubMed ID: 33495476
[TBL] [Abstract][Full Text] [Related]
27. Coagulation factor V is a marker of tumor-infiltrating immune cells in breast cancer.
Tinholt M; Stavik B; Tekpli X; Garred Ø; Borgen E; Kristensen V; Sahlberg KK; Sandset PM; Iversen N
Oncoimmunology; 2020 Sep; 9(1):1824644. PubMed ID: 33457104
[TBL] [Abstract][Full Text] [Related]
28. An Integrated Bioinformatic Analysis of the S100 Gene Family for the Prognosis of Colorectal Cancer.
Zeng ML; Zhu XJ; Liu J; Shi PC; Kang YL; Lin Z; Cao YP
Biomed Res Int; 2020; 2020():4746929. PubMed ID: 33294444
[TBL] [Abstract][Full Text] [Related]
29. Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.
André T; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt C; Smith D; Garcia-Carbonero R; Benavides M; Gibbs P; de la Fouchardiere C; Rivera F; Elez E; Bendell J; Le DT; Yoshino T; Van Cutsem E; Yang P; Farooqui MZH; Marinello P; Diaz LA;
N Engl J Med; 2020 Dec; 383(23):2207-2218. PubMed ID: 33264544
[TBL] [Abstract][Full Text] [Related]
30. Exploring subclass-specific therapeutic agents for hepatocellular carcinoma by informatics-guided drug screen.
Yang C; Chen J; Li Y; Huang X; Liu Z; Wang J; Jiang H; Qin W; Lv Y; Wang H; Wang C
Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33167027
[TBL] [Abstract][Full Text] [Related]
31. Identification prognosis-associated immune genes in colon adenocarcinoma.
Miao Y; Wang J; Ma X; Yang Y; Mi D
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140821
[TBL] [Abstract][Full Text] [Related]
32. FABP4 promotes invasion and metastasis of colon cancer by regulating fatty acid transport.
Tian W; Zhang W; Zhang Y; Zhu T; Hua Y; Li H; Zhang Q; Xia M
Cancer Cell Int; 2020; 20():512. PubMed ID: 33088219
[TBL] [Abstract][Full Text] [Related]
33. Discovering the anti-cancer potential of non-oncology drugs by systematic viability profiling.
Corsello SM; Nagari RT; Spangler RD; Rossen J; Kocak M; Bryan JG; Humeidi R; Peck D; Wu X; Tang AA; Wang VM; Bender SA; Lemire E; Narayan R; Montgomery P; Ben-David U; Garvie CW; Chen Y; Rees MG; Lyons NJ; McFarland JM; Wong BT; Wang L; Dumont N; O'Hearn PJ; Stefan E; Doench JG; Harrington CN; Greulich H; Meyerson M; Vazquez F; Subramanian A; Roth JA; Bittker JA; Boehm JS; Mader CC; Tsherniak A; Golub TR
Nat Cancer; 2020 Feb; 1(2):235-248. PubMed ID: 32613204
[TBL] [Abstract][Full Text] [Related]
34. Analysis of tumor microenvironment-related key mRNAs and construction of a prognosis signature in colon cancer.
Zhang Z; He G; Feng Q; Zheng P; Lv Y; Mao Y; Xu Y; Xu J
Clin Transl Med; 2020 Jun; 10(2):e104. PubMed ID: 32564522
[No Abstract] [Full Text] [Related]
35. Development and Clinical Validation of a Novel 4-Gene Prognostic Signature Predicting Survival in Colorectal Cancer.
Yuan Y; Chen J; Wang J; Xu M; Zhang Y; Sun P; Liang L
Front Oncol; 2020; 10():595. PubMed ID: 32509568
[TBL] [Abstract][Full Text] [Related]
36. Identification of Hub Genes Related to Carcinogenesis and Prognosis in Colorectal Cancer Based on Integrated Bioinformatics.
Gong B; Kao Y; Zhang C; Sun F; Gong Z; Chen J
Mediators Inflamm; 2020; 2020():5934821. PubMed ID: 32351322
[TBL] [Abstract][Full Text] [Related]
37. Targeting apoptosis in cancer therapy.
Carneiro BA; El-Deiry WS
Nat Rev Clin Oncol; 2020 Jul; 17(7):395-417. PubMed ID: 32203277
[TBL] [Abstract][Full Text] [Related]
38. Colorectal cancer statistics, 2020.
Siegel RL; Miller KD; Goding Sauer A; Fedewa SA; Butterly LF; Anderson JC; Cercek A; Smith RA; Jemal A
CA Cancer J Clin; 2020 May; 70(3):145-164. PubMed ID: 32133645
[TBL] [Abstract][Full Text] [Related]
39. Metastatic patterns and survival outcomes in patients with stage IV colon cancer: A population-based analysis.
Wang J; Li S; Liu Y; Zhang C; Li H; Lai B
Cancer Med; 2020 Jan; 9(1):361-373. PubMed ID: 31693304
[TBL] [Abstract][Full Text] [Related]
40. The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications.
Soldevilla B; Carretero-Puche C; Gomez-Lopez G; Al-Shahrour F; Riesco MC; Gil-Calderon B; Alvarez-Vallina L; Espinosa-Olarte P; Gomez-Esteves G; Rubio-Cuesta B; Sarmentero J; La Salvia A; Garcia-Carbonero R
Eur J Cancer; 2019 Dec; 123():118-129. PubMed ID: 31678770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
